Atlanta, GA, United States of America

Cesar G Albarino

This inventor holds 4 USPTO granted patents and 1 EPO patent. Top assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2014-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Cesar G Albarino. Retrieved from https://idiyas.com/inventor/cesar-g-albarino

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2014-2018

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations in Vaccine Development by Cesar G Albarino

Introduction

Cesar G Albarino is a prominent inventor based in Atlanta, GA (US), known for his significant contributions to the field of vaccine development. With a total of 4 patents, Albarino has focused on creating innovative solutions to combat infectious diseases, particularly those affecting livestock and humans.

Latest Patents

Albarino's latest patents include groundbreaking work on recombinant Rift Valley fever (RVF) viruses and methods of use. These recombinant RVF viruses feature deletions in one or more viral virulence genes, such as NSs and NSm. The viruses, generated using a plasmid-based reverse genetics system, serve as vaccines to prevent RVF virus infections in both livestock and humans. They are designed to grow to high titers, provide protective immunity following a single injection, and allow for differentiation between vaccinated animals and those infected with wild-type RVF virus.

Another notable patent involves Rift Valley fever virus replicon particles (VRP) and their use as a vaccine candidate. This robust system for reverse genetics generation allows VRP to actively synthesize viral RNA and proteins while lacking structural glycoprotein genes. This design prevents spread within immunized individuals and reduces the risk of vaccine-induced pathogenicity. Immunization with VRP has been shown to be both safe and efficacious, resulting in a strong immune response that protects against RVF virus challenge within 24 hours of immunization.

Career Highlights

Cesar G Albarino works for the United States of America, as represented by the Secretary, Department of Health and Human Services. His work has been instrumental in advancing vaccine technology and improving public health outcomes.

Collaborations

Albarino has collaborated with notable colleagues, including Brian H Bird and Stuart T Nichol, to further enhance the impact of his research and innovations in the field of infectious diseases.

Conclusion

Cesar G Albarino's contributions to vaccine development, particularly in the area of Rift Valley fever, highlight his role as a leading inventor in the field. His innovative approaches and collaborative efforts continue to pave the way for advancements in public health and disease prevention.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…